Genotyping Market Share, Trend, Global Demand, Key Players Review and Forecast to 2027

0
46

Market Synopsis:

Increasing burden of genetic disorders has raised awareness and encouraged investments for effective treatments. This, in turn, is likely to enable genotyping in gaining quick mileage over the next few years. According to the report circulated by Market Research Future (MRFR), the global genotyping market share is projected to register a CAGR of 22.5% during the assessment period 2018 to 2023.

Human genotyping is gaining momentum owing to the rising burden of genetic disorders. Also, the growing awareness about the same, coupled with the availability of government’s support, is expected to catalyze the proliferation of genotyping market. In addition, microorganism genotyping is expected to earn high revenues due to its extensive demand in the field of research & development. However, the lack of skilled personnel can pose a challenge to players of the genotyping market.

Regional Analysis:

The global genotyping market, on the basis of region, has been segmented into four regions – Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). Americas is leading the growth of the global market and is expected to maintain its pole position over the next couple of years. The region has been observing an increase in the burden of genetic disorders. This, in turn, has encouraged investments in research & development projects which is poised to boost the expansion of genotyping market in the region. Alzheimer’s Association published a report in 2018 stating that 5.7 million Americans had Alzheimer in that year. The same report revealed that the U.S. incurred a cost of USD 277 Bn for the disease. Other factors that are anticipated to accelerate revenue creation in the genotyping market in the region are the presence of developed healthcare industry, rising demand for personalized medicine, etc.

Market Segmentation:

Based on technology, the global genotyping market has been segmented into sequencing, PCR, microarray, capillary electrophoresis, and mass spectrometry. The capillary electrophoresis segment is further sub-segmented into single-strand conformation polymorphism (SSCP), amplified fragment length polymorphism (AFLP), and restriction fragment length polymorphism (RFLP). The sequencing segment has been sub-segmented into pyrosequencing, next-generation sequencing, and Sanger sequencing. Also, the microarray segment has been sub-segmented into antibody microarrays, DNA microarrays, MM Chips, and peptide microarrays.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

Leave a reply